PATENT CLAIM ANALYSIS

Application Number: 15761995
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
Provided herein are methods for treating, preventing, or ameliorating one or more symptoms of a condition, disorder, or disease mediated by a lipid kinase or a protein kinase with benzimidazoles, for example, of Formula I or II, and pharmaceutical compositions thereof. Also provided herein are benzimidazoles, and pharmaceutical compositions thereof; and methods of their use for treating, preventing, or ameliorating one or more symptoms of a proliferative disease.

Claim (Index 123):
The compound of  claim 121 , wherein R 1b  and R 1c  are each independently methyl or isopropyl, each of which is optionally substituted with one or more substituents Q; or R 1b  and R 1c  together with the N atom to which they are attached form aziridinyl, azetidinyl, pyrrolidinyl, morpholinyl, piperidinyl, piperazinyl, or 1,1-dioxo-thiomorpholinyl, each of which is optionally substituted with one or more substituents Q.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 96.0
- Lexical Diversity: 2.025
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15127000', '16005490', '14489231', '13431716', '13830712']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8087259710767385
- 35 USC 102 Novelty (BERT): 0.5780044073246632
- Combined Prediction Score: 0.7856538147015311
- Mean Citation Score: 435.272624
- Max Citation Score: 474.12836
- Similarity Product: 391.1477523952365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test